Therakind
Pre-clinicalOur expertise lies in the identification of patient needs through the reformation and development of approved and novel medications to improve patient’s lives, either through our own portfolio or working in collaboration with partners.
Founded
2013
Focus
Small Molecules
About
Our expertise lies in the identification of patient needs through the reformation and development of approved and novel medications to improve patient’s lives, either through our own portfolio or working in collaboration with partners.
Funding History
2Total raised: $1.5M
Seed$1.5MUndisclosedMay 15, 2017
GrantUndisclosedEuropean CommissionJun 15, 2015
Company Info
TypePrivate
Founded2013
LocationLondon, United Kingdom
StagePre-clinical
Contact
SIMILAR COMPANIES
Abbexa
Pre-clinical · Cambridge
Accentus Medical
Pre-clinical · Oxford
AbOliGo
Pre-clinical · London
Bigespas
Pre-clinical · London
Actimed Therapeutics
Pre-clinical · London
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile